'Here comes the story of the Hurricane': a case report of AL cardiac amyloidosis and myocardial bridging
Luigi Cappannoli, Giuseppe Ciliberti, Attilio Restivo, Pierpaolo Palumbo, Francesco D'Alò, Tommaso Sanna, Filippo Crea, Domenico D'Amario, Luigi Cappannoli, Giuseppe Ciliberti, Attilio Restivo, Pierpaolo Palumbo, Francesco D'Alò, Tommaso Sanna, Filippo Crea, Domenico D'Amario
Abstract
Background: Cardiac amyloidosis (CA) is a rapidly progressive infiltrative cardiomyopathy, whose role is emerging as a not-so-rare disorder leading to heart failure (HF). Myocardial bridge (MB) is the most common inborn coronary artery variant, and its clinical relevance is still matter of debate. The exceptional coexistence of these two conditions could accelerate disease progression and worsen the already compromised clinical conditions.
Case summary: We present the case of a 76-year-old female patient experiencing relapsing HF decompensation and presenting to our centre with dyspnoea at rest and severe peripheral congestion. Echocardiogram showed severe concentric hypertrophy, severe biventricular contractile dysfunction, and third-degree diastolic dysfunction. Coronary angiography excluded epicardial atherosclerotic disease, though displaying a long intramyocardial course of left anterior descending artery. Physiological invasive test was achieved in terms of instantaneous wave-free ratio (iFR), both at baseline and after inotropic and chronotropic stimuli, and attested haemodynamic significance. Concurrently, the diagnostic flow chart for CA was accomplished, by means of both invasive (periumbilical fat biopsy, bone marrow aspiration) and non-invasive tests (99mTc-diphosphonate scintigraphy, serum-urine immunofixation) that confirmed the suspect of primary amyloidosis. Acute HF therapy was personalized according to the singularity of the case, avoiding both nitrates and beta-blockers, then first cycle of chemotherapy was started.
Discussion: Our clinical case shows a unique interaction between infiltrative cardiomyopathy and coronary artery abnormality. Amyloidosis can contribute to the ischaemic burden of the MB and this may, in turn, abbreviate the path to HF decompensation.
Keywords: Cardiac amyloidosis; Case report; Functional intracoronary assessment; Heart failure; Myocardial bridge.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures
References
- Basile U, Rosa GLA, Napodano C, Pocino K, Cappannoli L, Gulli F, Cianfrocca C, Di Stasio E, Biasucci LM. Free light chains a novel biomarker of cardiovascular disease. A pilot study. Eur Rev Med Pharmacol Sci 2019;23:2563–2569.
- Falk RH, Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am College Cardiol 2016;68:1323–1341.
- Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio AL, Damy T, Eriksson U, Fontana MGillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021;42:1554–1568.
- Lee MS, Chen C-H. Myocardial bridging: an up-to-date review. J Invasive Cardiol 2015;27:521–528.
- D’amario D, Cammarano M, Quarta R, Casamassima F, Restivo A, Bianco M, Palmieri V, Zeppilli P. “A bridge over troubled water”: a case report. Eur Hear J Case Rep 2021;5:ytab109.
- Hoffman JE, Dempsey NG, Sanchorawala V. Systemic amyloidosis caused by monoclonal immunoglobulins: soft tissue and vascular involvement. Hematol/Oncol Clin North Am 2020;34:1099–1113.
- Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA 2020;324:79–89.
- Kyriakou P, Mouselimis D, Tsarouchas A, Rigopoulos A, Bakogiannis C, Noutsias M, Vassilikos V. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. BMC Cardiovasc Disord 2018;18:221.
- Modesto KM, Dispenzieri A, Gertz M, Cauduro SA, Khandheria BK, Seward JB, Kyle R, Wood CM, Bailey KR, Tajik AJ, Miller FA, Pellikka PA, Abraham TP. Vascular abnormalities in primary amyloidosis. Eur Heart J 2007;8:1019–1024.
- Dorbala S, Vangala D, Bruyere J, Quarta C, Kruger J, Padera R, Foster C, Hanley M, Di Carli MF, Falk R. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Hear Fail 2014;2:358–3567.
- Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA, Selvanayagam JB, Neubauer S, Watkins H. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy new insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418–2425.
- Villa ADM, Sammut E, Zarinabad N, Carr-White G, Lee J, Bettencourt N, Razavi R, Nagel E, Chiribiri A. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson 2015;18:4.
- Murtaza G, Mukherjee D, Gharacholou SM, Nanjundappa A, Lavie CJ, Khan AA, Shanmugasundaram M, Paul TK. An updated review on myocardial bridging. Cardiovasc Revasc Med 2020;21:1169–1179.
- Sara JDS, Corban MT, Prasad M, Prasad A, Gulati R, Lerman LO, Lerman A. Prevalence of myocardial bridging associated with coronary endothelial dysfunction in patients with chest pain and non-obstructive coronary artery disease. EuroIntervention 2020;15:1262–1268.
- Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM1 and monocyte adherence in arteries exposed to altered shear stress. Aterioscler Thromb Vasc Biol 1995;15:2–10.
- McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Hear Circ Physiol 2003;285:H2290–H2297.
- Monroy-Gonzalez AG, Alexanderson-Rosas E, Prakken NHJ, Juarez-Orozco LE, Walls-Laguarda L, Berrios-Barcenas EA, Meave-Gonzalez A, Groot JC, Slart RHJA, Tio RA. Myocardial bridging of the left anterior descending coronary artery is associated with reduced myocardial perfusion reserve: a 13N-ammonia PET study. Int J Cardiovasc Imaging 2019;35:375–382.
- Tarantini G, Barioli A, Nai Fovino L, Fraccaro C, Masiero G, Iliceto S, Napodano M. Unmasking myocardial bridge-related ischemia by intracoronary functional evaluation. Circ Cardiovasc Interv 2018;11:e006247.
- Guan J, Mishra S, Qiu Y, Shi J, Trudeau K, Las G, Liesa M, Shirihai OS, Connors LH, Seldin DC, Falk RH, MacRae CA, Liao R. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med 2014;6:1493–1507.
Source: PubMed